Royal Bank of Canada reaffirmed rating, Citigroup began coverage, and Morgan Stanley boosted price target on Arrowhead Pharmaceuticals.
1 report, 1 independent
Updated Sep 11
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Royal Bank of Canada reaffirmed rating, Citigroup began coverage, and Morgan Stanley boosted price target on Arrowhead Pharmaceuticals.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Arrowhead Pharmaceuticals
biopharmaceutical company
Nothing else this week.
-
Royal Bank of Canada
financial institution in Canada
-
Citigroup
American investment bank and financial services corporation
-
Morgan Stanley
U.S. investment bank
Related events
- Royal Bank of Canada, Citigroup, and Morgan Stanley issued price target and rating updates on August 27, 2026.
- Citigroup raised its target price and Royal Bank of Canada boosted its price objective for Carrier Global Corporation on August 26, 2026.
- RBC raised its price objective, Citigroup reaffirmed its outperform rating, and Bank of America reiterated its neutral rating for Addus HomeCare Corporation.
- Bank of America, Citigroup, and Royal Bank of Canada issued rating upgrades and price target increases for International Paper.
- Royal Bank of Canada provided a price target and reaffirmed a sector perform rating for Plains All American Pipeline.